MedPath

Amryt Pharmaceuticals Dac

🇧🇪Belgium
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:2
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

8

SFDA:4
FDA:3
EMA:1

Drug Approvals

FILSUVEZ

Approval Date
Feb 14, 2024
FDA

Juxtapid

Approval Date
Apr 28, 2022
FDA

Myalept

Approval Date
Mar 10, 2022
FDA

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.